Abstract. Glomerular mesangial cells (GMCs) have a finite cell lifespan and eventually enter irreversible growth arrest known as cellular senescence. The functional changes associated with cellular senescence are thought to contribute to human aging and age-related kidney disorders, such as chronic kidney disease. Angiotensin II (AngII), a principal effector of the renin-angiotensin system (RAS), is known to promote aging and cellular senescence. The cellular and molecular mechanisms responsible for the senescence of GMCs remain largely undefined. The JAK2/STAT pathway plays a pivotal role in transmitting cytokine signals. To date, little is known regarding the relationship between AngII or STAT protein and aging human GMCs. Therefore, this study was designed to determine the effects of AngII and the JAK2/STAT pathway on the process of GMC aging. We observed the functions of the AngII receptor blocker losartan and the JAK2 blocker AG490 in delaying GMC aging. Cells were assigned to a control group, an AngII-induced group, a losartan + AngIIstimulated group and an AG490 + AngII-treated group. AngII promoted growth arrest with phenotypic characteristics of cell senescence, such as enlarged cell morphology, polymorphic nuclei and vacuolization, increased staining for senescenceassociated β-galactosidase, and depressed cell proliferation. The JAK2/STAT1/3 pathway is drastically activated in AngIIinduced senescence cells. Compared to the AngII-induced group, in the cells treated with losartan and AG490, the characteristics of cell senescence were ameliorated, and the expression of STAT1, STAT3, pSTAT1 and pSTAT3 was decreased. Our results suggest that AngII induces human GMC senescence, and that the JAK2/STAT1/3 pathway is involved in this process. By applying losartan and blocking the JAK2/STAT pathway, it may be possible to delay GMC aging.
Introduction
Aging is associated with a degenerative effect on many organs, including the kidney. Studies confirm the near exponential rise in chronic kidey disease with age, and the need for renal replacement therapy among these patients is rapidly increasing (1-4). The molecular basis of age-related changes in the kidney is unknown; however, organ aging may reflect aspects of cellular senescence. Glomerular mesangial cells (GMCs) are the most important and active cells of the kidney, regulating renal blood flow, excreting extracellular matrix and mediating inflammation. Changes in the phenotype and function of GMCs must produce considerable effect. Angiotensin II (AngII), a major component of the renin-angiotensin system (RAS), plays a primary role as a vasoconstrictor in controlling renal homeostasis. Besides its action as a potent hypertensive hormone, AngII has various biological effects on cell proliferation, migration and invasion. Recent evidence suggests that AngII may play an important role in aging (5-7). Previous studies have shown that cultured endothelial cells exposed to AngII undergo arrest in the G 1 phase of the cell cycle, with increased expression of the cyclin-dependent kinase (CDK) inhibitors p21 and p27, which are markers of cell senescence (8-10). It has been reported that angiotensin converting enzyme inhibitors (ACEIs) and AngII receptor blockers (ARBs) have not only hypotensive, but also protective effects on the progression of kidney aging (11) (12) (13) .
The cellular and molecular mechanisms responsible for the senescence of GMCs remain largely undefined, and the upstream elements involved in the signaling pathways are presently unknown. Among these signaling molecules, the signal transducers and activators of transcription (STATs) are proteins that play a pivotal role in transmitting cytokine signals. Inactive cytoplasmic STATs are activated through tyrosine phosphorylation and dimerize before translocating into the nucleus to activate the transcription of the target gene. Among the seven members of the mammalian STAT family, STAT1 and STAT3 have been the most strongly implicated in the genesis of aging (14, 15) . Previous studies have shown that AngII activates STAT1 and STAT3 signaling in various cells (16) (17) (18) (19) . Changes in STAT1 and STAT3 protein vary among aging cells (20) . To date, nothing is known regarding the relationship between aging human GMCs and STAT protein.
We hypothesized that AngII may induce human GMC senescence. We further investigated whether AngII induces human GMC senescence via the JAK2/STAT pathway, and examined the function of losartan in delaying GMC aging. Additionally, we examined age-related changes after treatment with AG490, the specific blocker for JAK2. Elucidation of the mechanisms underlying these changes may provide valuable insight into the sequence of events that occurs during the establishment of the senescent phenotype.
Materials and methods
Materials. Human mesangial cell medium was from the American Science Cell Co. Rabbit monoclonal antibodies specific for STAT1, STAT3, pSTAT1 and pSTAT3 were obtained from Cell Signaling Technology. AngII and AG490 were from Sigma, and losartan was kindly provided by Merck.
Cell culture. Mesangial cells were obtained from ScienCell Research Laboratories (Carlsbad, CA, uSA) and cultured in mesangial cell medium supplemented with 10% fetal bovine serum, 100 u/ml penicillin and 100 µg/ml streptomycin at 37˚C in a humidified atmosphere of 5% CO 2 in air. The cells were grown to 80-90% confluence in 25-cm 2 culture flasks and subcultured at a ratio of 1:2. Cells from passages 5-8 were used. For the experiments, the cells were seeded and grown for 24 h, then maintained in serum-free medium for 12 h to ensure G 0 arrest. At this point, a final concentration of angii (10 -6 mol/l) was added to the culture medium, and cells were stimulated for 72 h. Losartan (10 -5 mol/l) and AG490 (10 µmol/l) were added 1 h prior to the addition of AngII. Medium overlying the cells was supplemented with AngII, losartan or AG490 on alternate days.
Cell viability assay. To assess cell viability, 1x10 3 cells/well were seeded in 96-well microtiter plates and allowed to adhere to the plate for 24 h. Cells were then treated with 10 -8 , 10 -7 , 10 -6 , 10 -5 or 10 -4 mol/l AngII (6 wells/group). After incubation for 24, 48, 72 and 96 h, respectively, 20 µl of 5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide (MTT) was added to each well, and cells were incubated for an additional 4 h at 37˚C. Dimethyl sulfoxide (150 µl) was added to the wells to dissolve the formazan crystals. Absorbance (optical density, OD) was measured at 570 nm. The percentage of live cells was calculated as the OD of experimental cells/OD of control cells x 100.
Senescence-associated β-galactosidase staining. The senescence of cells was verified by in situ staining for senescence-associated β-galactosidase (SA-β-gal), as previously described. Briefly, cells growing on 24-well microtiter plates were washed three times with phosphate-buffered saline (PBS), then fixed with 2% formaldehyde/2% glutaraldehyde in PBS for 3-5 min at room temperature. The cells were then washed again and incubated overnight at 37˚C (without CO 2 ) with freshly prepared Sa-β-gal staining solution containing 1 mg/ml X-gal, 40 mM citric acid/sodium phosphate (pH 6.0), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM naCl and 2 mM Mgcl 2 . Cells were then rinsed with PBS, and 100-200 cells in six microscopic fields were counted to determine the percentages of SA-β-gal positively stained cells.
Cell cycle analysis. To analyze the cell cycle profile, cells were digested with 0.25% trypsinase, washed with PBS and fixed in 70% methanol at 4˚C overnight. Cells were then resuspended in PBS with Rnase A (100 g/ml) and incubated for 30 min at 37˚C. Then, the cells were stained with propidium iodide (20 µg/ml) for 30 min and analyzed by FACScan flow cytometry using linear amplification. For each sample, 20,000 events were collected, and aggregated cells were gated out. Data were analyzed by auto-analysis function ModFitLT3.0 software.
Optical microscopy and ultra-microstructure. Morphologic changes in the senescent cells were evaluated using optical microscopy. Cells were washed twice with PBS and examined using an Olympus optical microscope. Transmission electron microscopy was used to evaluate the ultra-microstructure. Cells were washed twice with PBS and fixed in 2.5% glutaraldehyde in 0.2 M cacodylate buffer (pH 7.4) at 4˚C for 2 h, then washed in PBS and postfixed in 1% OsO 4 for 1 h. After washing in PBS, the samples were dehydrated in a graded series of ethanol and acetone, and embedded in Epon 812. ultrathin sections (70-nm) were cut on a Leica ultracut uCT ultramicrotome. After staining with uranyl acetate and lead citrate, the sections were examined using a Hitachi H500 transmission electron microscope at 75 kV.
Immunofluorescence detection. expression of STaT1, STaT3, pSTAT1 and pSTAT3 was analyzed by immunofluorescence staining. Briefly, cells were cultured on glass slides for 72 h, then fixed with ice-cold 4% formalin solution in PBS for 10 min at 4˚C. After blocking with 3% hydrogen peroxide for 10 min and 5% bovine serum albumin for 2 h, they were incubated with monoclonal rabbit antibodies against human STAT1, STAT3, pSTAT1 and pSTAT3 overnight at 4˚C, and then with a goat anti-rabbit IgG at 37˚C for 1 h after extensive washing between each step. Monoclonal rabbit antibodies against human STAT1, STAT3 and pSTAT1, pSTAT3 dilutions were used as recommended by the manufacturers.
Western blot analysis. At each time point (0, 24, 48, 72, 96 and 120 h) cells were lysed on ice in lysis buffer, then PMSF was added. Cell extracts were collected after supersonic quassation and centrifugation of the cell lysates at 12,000 x g for 5 min at 4˚C. Protein concentration was determined with a BCA protein assay reagent kit. An equal amount of protein (20 µg/lane) from each cell extract was resolved on an 8% SDS-PAGE gel and electroblotted onto a PVDF membrane. Blots were blocked with TBS-T blocking buffer (5% non-fat milk in 25 mM Tris-HCl, pH 8.0, 3 mM KCl, 150 mM naCl and 0.05% Tween), and subsequently probed with a relevant primary antibody at a predetermined optimal concentration for 2 h at room temperature. After three washes with TBS-T, the immunoblots were incubated with an appropriate peroxidase-conjugated secondary antibody for 1 h at room temperature, then developed using an ECL Western blotting detection system and recorded by exposure to X-ray film.
Statistical analysis. Data were expressed as the means ± standard deviation (SD). Differences were evaluated by AnOVA. Statistical significance was defined as p<0.05.
Results

Cell viability assay.
To evaluate cell viability, we examined the various concentrations of AngII required to induce cellular senescence in GMCs during a 96-h period. using MTT assays, we demonstrated that cellular proliferation was slightly higher in the AngII-induced groups than in the control group after 24 or 48 h of incubation. After 72 h of incubation, cellular proliferation was permanently inhibited in the AngII-induced groups, with an OD value significantly lower than that of the control group (Fig. 1) . Viability with 10 -6 mol/l AngII was 81.09±4.52% (p<0.01). There was no significant difference between the viability of cells stimulated with 10 -7 and 10 -8 mol/l AngII and the control cells, whereas the viability of cells stimulated by 10 -4 and 10 -5 mol/l AngII was decreased compared to the control cells (49.13±3.32 and 51.18±3.48%; p<0.01). Therefore, the senescent model of GMCs was established using 10 -6 mol/l AngII.
AngII-induced GMC senescence. We first determined whether AngII stimulates the cellular senescence of GMCs using Sa-β-gal staining, a reliable biomarker for cellular senescence. Increased staining of SA-β-gal has been reported in aging cells when these have been assayed at a near-neutral pH of 6.0. In the present study, SA-β-gal staining was significantly increased in the AngII-induced cells compared to the control cells (83.10±6.71 and 3.18±0.04%; p<0.01) ( Fig. 2A and B (Fig. 3A and B) . These results indicated that the cells were arrested by AngII at the G 0 /G 1 phase. Optical and transmission electron microscopy were used to evaluate morphologic and ultra-microstructure alterations in the GMCs. Senescent cells were characterized by enlarged cell morphology, polymorphic nuclei, chromatin condensation at the nuclear margin, invagination of the nuclear membrane, the disappearance of mitochondria and pulp-lysosome identified in aging cells ( Fig. 4B and F) . The control cells had a round and smooth morphology, and even chromatin distribution ( Fig. 4A and E) .
Increase in STAT1/3 during aging. To determine changes in STAT1/3 during the process of GMC senescence stimulated by AngII, immunofluorescence detection and Western blot analysis were performed. AngII selectively induced STAT1 and STAT3 activation in the GMCs. The exposure of the cells to 10 -6 mol/l AngII resulted in the activation of STAT1 and STAT3, as manifested by an increase in STAT phosphorylation. using immunofluorescence detection, we found that STAT1, STAT3, pSTAT1 and pSTAT3 were expressed in the cytoplasm and cytoblast in normal GMCs, and were increased in AngII-induced aging cells, in particular in the cytoblast (Fig. 5) . Western blot analysis indicated that STAT1, STAT3, pSTAT1 and pSTAT3 levels were also increased in the aging cells compared to the control cells. upon exposure to losartan and AG490, STAT expression in the aging cells was decreased (Fig. 6 ). As shown in Fig. 7 , the increase in STAT3 and pSTAT3 peaked at 48 h and lasted for 72 h, declining to the basal level at 96 h after exposure to AngII. The increase in STAT1 and pSTAT1 peaked at 24 h and lasted for 72 h, declining to the basal level at 96 h after exposure to AngII. These results suggest that the exposure of GMCs to AngII activates STAT1 and STAT3.
Function of losartan in delaying GMC aging.
MTT assays demonstrated that the cellular proliferation capacity of GMCs was ameliorated in cells exposed to losartan. OD values were higher in these cells than in the aging cells stimulated with AngII. Cell viability was 94.95±5.12%. SA-β-gal staining was decreased in the losartan + AngII-stimulated group as compared to the AngII-induced group (42.13±3.61 and 83.10±6.71%; p<0.01) (Fig. 2B and C) . Cell cycle analysis indicated that the cell percentage at the G 0 /G 1 , S and g 2 /M phases was normalized ( Fig. 3B and C) . Optical microscopy and transmission electron microscopy revealed losartan + AngII-stimulated cells to be regularly aligned, with decreased pulp-lysosome and a smooth nuclear membrane ( Fig. 4C and G) .
Function of blocking JAK2/STAT in delaying GMC aging.
MTT assays demonstrated that the cellular proliferation capacity of GMCs was ameliorated in cells exposed to AG490. OD values were higher in these cells than in the aging cells stimulated by AngII. Cell viability was 95.61±5.12%. SA-β-gal staining was decreased in the AG490 + AngII-stimulated group as compared to the AngII-induced group (46.28±3.73 and 83.10±6.71%; p<0.01) (Fig. 2B and D) . Cell cycle analysis indicated that the cell percentage at the G 0 /G 1 , S and g 2 /M phases was near to normal ( Fig. 3B and D) . Optical microscopy and transmission electron microscopy revealed AG490 + AngII-stimulated cells to be regularly aligned, with nuclear membrane invagination and a decreased pulp-lysosome ( Fig. 4D and H) .
Discussion
The natural process of aging is associated with the progressive modification and, ultimately, the loss of organ function. The kidney is also affected by the aging process. Much attention has been devoted to the study of the effects of aging on the kidney. It is well known that kidney function is slightly decreased with aging. The kidney exhibits greater ageassociated deterioration than most organs, even in the absence of cardiovascular disease (21). Age-associated changes in the kidney are important, not only because normal aging alters renal function, but also because of the high frequency of end-stage renal disease (ESRD) in the elderly. The number of patients with ESRD in the Western world is progressively increasing due to an increase in the number of patients over 65 years of age (22) . understanding the mechanisms of declining organ function with age may elucidate the mechanisms of decline in disease states.
Over the past 20 years, we have investigated the age-related mechanisms and alterations involved in this process, focusing on the role of RAS in the aging process. Recent studies have provided increasing evidence that AngII may also play an important role in aging (5) (6) (7) 23) . We observed that SA-β-gal staining was significantly increased in the AngII-induced cells compared to the control cells. Cell cycle analysis showed that the cells were arrested in the G 0 /G 1 phase, which indicates that AngII promoted cellular senescence in the GMCs. It has been reported that cells that have undergone replicative senescence in culture show distinctive changes in morphology, such as an enlarged cell morphology, polymorphic nuclei and vacuolization. These characteristics were apparent in our findings, thus indicating that AngII successfully induced GMC senescence and established a senescence model.
STAT expression during aging is the subject of some controversy. It has been reported that STAT3 and pSTAT3 expression is up-regulated in cultured human senescent fibroblasts (18) and aging T-cells (24); nevertheless, other studies have demonstrated their expression to be down-regulated with age in rat brain (24) and heart (20) cells. STAT1 and pSTAT1 expression is down-regulated in rat macrophage cells (25). These contradictory results could be explained on the basis of cell specificity and different aging rates between species and organs. In this regard, we observed STAT1, STAT3 and pSTAT1, pSTAT3 alterations during the process of GMC senescence induced by AngII. In agreement with our research, a great deal of evidence indicates the enhanced activity of a specific signaling transduction pathway contributing to aging. In the present study, to firmly elucidate the function of the JAK2/STAT signaling transduction pathway during aging, we observed alterations in cell morphology after exposure to AG490, the JAK2 blocker. Our results showed that senescence-related indices were ameliorated (cell viability was increased, cell cycle proportion was normalized, SA-β-gal positively stained cells were decreased, cell morphology and ultra-microstructure changes were reversed) in the AG490-stimulated cells compared to the AngII-induced cells. This appeared to be due to the process of aging, and not to the AngII activation of the JAK2/STAT pathway, although this pathway can be activated by AngII in and of itself.
Consistent with a key role for AngII in age-related kidney disease are reports that AngII blockers attenuate the renal effects observed in aging. In the majority of cases, inhibition of RAS by ACEIs or ARBs has proved effective in improving renal structure and function in aging mice and rats (26, 27) . Previous studies have demonstrated that chronic administration of losartan prevents age-associated changes in the rat kidney (28). In this regard, we observed the func- tion of losartan in delaying GMC aging. SA-β-gal staining was significantly decreased in the losartan-stimulated cells compared to the AngII-induced cells. Cell cycle analysis indicated that the number of cells in the G 0 /G 1 phase was increased; morphology and ultra-microstructure changes such as enlarged cell morphology, polymorphic nuclei, vacuolization and invagination of the nuclear membrane were not apparent. These findings indicate that losartan may play a role in preventing GMC senescence.
To our knowledge, this is the first study demonstrating that AngII induces the cellular senescence of GMCs via the JAK/ STAT1/3 pathway. Although increasing evidence indicates that the signal transduction pathway is activated in aging tissues or cells, the role of JAK2/STAT in the GMC aging process is poorly understood. Further studies on the mechanisms leading to senescence using in vitro senescent cells may contribute to our understanding of the role of JAK2/STAT in the aging process. In summary, the data presented in this study demonstrate that AngII induces GMC senescence, whereas the induction of normal cell senescence may rely on the JAK2/STAT pathway. Therefore, a better understanding of the mechanisms by which AngII induces normal cell senescence would be beneficial to the development of new therapeutics, more effective in depleting aging cells and limiting toxicity to normal tissues.
